The global virtual clinical trials market is anticipated to grow at a considerable CAGR of 8.5% during the forecast period (2023-2030). The number of trials involving mobile healthcare, has more than doubled in usage from 2019 to 2021. The ongoing market developments to promote the usage of virtual clinical trials are a key factor driving the market growth. For instance, in May 2023, NetraMark has released a new clinical trial de-risking technology called NetraGPT, which integrates ChatGPT. NetraGPT is based on hypotheses created from the firm’s proprietary good clinical practice (GCP) validated AI/ML system known as NetraAI.
Browse the full report description of “Virtual Clinical Trials Market Size, Share & Trends Analysis Report by Study Design (Observational, Interventional, and Expanded Access), and by Indication (Cardiovascular Diseases (CVDs), Oncology, and Others) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/virtual-clinical-trials-market
The NetraAI system has the capability to learn special combinations of variables that define patient subpopulations in the context of drug or placebo responses and adverse effects, which are important aspects of clinical trials. NetraGPT consumes data on specific clinical trial patient subpopulations identified by NetraAI. This process includes feeding various variables, biological or otherwise, which are statistically important for the dis8/covered subpopulations, based on the dependent variable, such as drug response, placebo response, placebo non-response, adverse events, and others. Based on these feeds, NetraGPT provides comprehensive, human-readable reports driven by large language models (LLMs).
Further, in January 2023, Kroger Health had launched a clinical trial site network. It will work with trial sponsors, contract research organizations and health systems to conduct clinical trials out of select Kroger pharmacies and clinics. It will also use virtual care and digital health tools to ensure patients stay enrolled in clinical trials.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Study Design
o By Indication
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes ICON PLC, Laboratory Corporation of America Holdings (Covance Inc.), Oracle Corp., Parexel International Corp., and IQVIA Holdings Inc., among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Virtual Clinical Trials Market Report Segment
By Study Design
By Indication Type
Global Virtual Clinical Trials Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/virtual-clinical-trials-market